Document is current
Any future updates will be listed below
-
Authors
Farrell, Sam H.
Anderson, Roy M.
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1053230)
- License Information
-
More Information
Article History
Received: 23 November 2017
Accepted: 23 January 2018
First Online: 31 January 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Roy Anderson is a Non-Executive Director of GlaxoSmithKline (GSK). GSK had no role in the funding of this research or this publication. Sam Farrell declares that he has no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
